Status:
COMPLETED
Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Migraine Disorders
Eligibility:
All Genders
20-60 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine which drug makes lower migraine headache
Detailed Description
There are different options to manage benign headache in emergency department.The investigators compared Intravenous metoclopramide with Subcutaneous sumatriptan to relieve pain in emergency departmen...
Eligibility Criteria
Inclusion
- 20-60 years old and presented with acute headache similar to previous episodes,
- with or without phonophobia,
- photophobia,
- vomiting or nausea.
Exclusion
- fever or neck stiffness,
- altered mental state,
- pregnancy,
- recent trauma or seizure (within 24 hours),
- focal neurological abnormality on physical examination,
- allergy to metoclopramide,
- hypertension,
- cardiovascular diseases.
- Also if the patients had taken a triptan or ergot during the last 24 hours were excluded from the study.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT01791400
Start Date
July 1 2009
End Date
November 1 2010
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-zahra university hospital
Isfahan, Isfahan, Iran